Skip to main content

Table 1 Setting-specific model inputs for Analyses II and III, adapted from the global model [4] and adopting all other global model assumptions, including generic inputs from the DEB model.[16, 17]

From: Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation

Region

R0

α

pd

κ

tr

POL3

TC

Prm

poro

# tOPV SIAs in 2015

Year of IPV introduction

Hypothetical switch date

Analysis II:

            

Hypothetical population

10 or 13

0

NA

0.35

0.6

0.3

0.8

0.7

0.3

2

2015

Variable after last SIA in 2015

Analysis III:

            

Population like northern India

13

0.2

180

0.35

0.6

   

0.3

2

2015

 

 - Pop. A, subpop. 0 (under-vacc.)

     

0.3

0.8

0.7

   

Mid-2015

 - Pop. A, subpop. 1 (general)

     

0.6

0.95

0.5

   

Mid-2015

 - Pop. B, subpop. 0 (under-vacc.)

     

0.3

0.8

0.7

   

April 1, 2016

 - Pop. B, subpop 1 (general)

     

0.6

0.95

0.5

   

April 1, 2016

Population like northern Pakistan/Afghanistan

11

0.2

180

0.35

0.65

   

0.3

 

2015

 

 - Pop. A, subpop. 0 (general)

     

0.6

0.8

0.7

 

2

 

Mid-2015

 - Pop. A, subpop. 1 (general)

     

0.6

0.8

0.7

 

2

 

Mid-2015

 - Pop. B, subpop. 0 (under-vacc.)

     

0.1

0.35

0.95

 

3

 

April 1, 2016

 - Pop. B, subpop 1 (general)

     

0.6

0.8

0.7

 

2

 

April 1, 2016

Population like Ukraine

6

0.4

180

0.45

0.74

   

0.8

0

2005

 

 - Pop. A, subpop. 0 (general)

     

0.7a

0.8

0.7

   

Mid-2015 

 - Pop. A, subpop. 1 (general)

     

0.7a

0.8

0.7

   

Mid-2015

 - Pop. B, subpop. 0 (under-vacc.)

     

0.3 a

0.8

0.7

   

April 1, 2016

 - Pop. B, subpop 1 (under-vacc. )

     

0.3a

0.8

0.7

   

April 1, 2016

  1. Model input symbols: [3, 16] R 0 average annual basic reproduction number for WPV of serotype 1, α seasonal amplitude of R0, defined as the “proportional change in R0 due to seasonality” [16, p. 717], pd peak day of R0, κ strength of preferential mixing between age groups, defined as the “proportion of contacts reserved for individuals within the same mixing age group”[16, p. 717], tr take rate of serotype 2 tOPV, POL3 RI coverage with 3 or more non-birth doses, TC true coverage of each SIA, P rm repeated missed probability of each SIA, poro, proportion of transmissions via oropharyngeal route
  2. aAssume POL3 = 90 % prior to 2010